Search Results - Dordal, Margaret

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Phase I trial of orally administered CEP-701, a novel neurotrophin receptor-linked tyrosine kinase inhibitor

    Phase I trial of orally administered CEP-701, a novel neurotrophin receptor-linked tyrosine kinase inhibitor by Marshall, John L, Kindler, Hedy, Deeken, John, Bhargava, Pankaj, Vogelzang, Nicholas J, Rizvi, Naiyer, Luhtala, Taina, Boylan, Stacy, Dordal, Margaret, Robertson, Philmore, Hawkins, Michael J, Ratain, Mark J

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Single-Dose Pharmacokinetics of Atrasentan, an Endothelin-A Receptor Antagonist

    Single-Dose Pharmacokinetics of Atrasentan, an Endothelin-A Receptor Antagonist by Samara, Emil, Dutta, Sandeep, Cao, Guoliang, Granneman, G. R., Dordal, Margaret S., MD, R. J. Padley

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    High levels of doxorubicin in the tissues of a patient experiencing extravasation during a 4‐day infusion

    High levels of doxorubicin in the tissues of a patient experiencing extravasation during a 4‐day infusion by Dorr, Robert T., Dordal, Margaret S., Koenig, L. Michael, Taylor, Charles W., McCloskey, Thomas M.

    Published in Cancer
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:

Search Tools: